Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-010201

Options or other derivatives

  • Director acquired 71,970 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Van Hulst Jack · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-02-19 Grant or award : show line 1 in the form Common Stock Option +71,970 $0.13 2023-02-19 71,970 1,355,947 D
Loading xslF345X03/form457954_20130220025731-.xml…